CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...